Befunolol
| (IUPAC) ime | |
|---|---|
| (RS)-17-[2-hidroksi-3-(propan-2-ilamino)propoksi]- 1-benzofuran-2-il | |
| Klinički podaci | |
| Identifikatori | |
| ATC kod | ? |
| Hemijski podaci | |
| Formula | ? |
| Farmakoinformacioni podaci | |
| Trudnoća | ? |
| Pravni status | |
etanon
| image = Befunolol.svg | width = | image2 = | width2 =
| tradename = Benfuran, Bentos, Betaclar, Glauconex | Drugs.com = Internacionalno ime leka | pregnancy_AU = | pregnancy_US = | pregnancy_category = | legal_AU = | legal_CA = | legal_UK = | legal_US = | legal_status = | routes_of_administration =
| bioavailability = | protein_bound = | metabolism = | elimination_half-life = | excretion =
| CASNo_Ref = 
| CAS_number_Ref =
| CAS_number = 39552-01-7
| ATC_prefix = S01
| ATC_suffix = ED06
| PubChem = 2309
| IUPHAR_ligand =
| DrugBank_Ref = Šablon:Drugbankcite
| DrugBank =
| ChemSpiderID_Ref =
| ChemSpiderID = 2219
| UNII_Ref =
| UNII = 418546MT3A
| KEGG_Ref =
| KEGG = D07496
| ChEMBL_Ref =
| ChEMBL = 153984
| C=16 | H=21 | N=1 | O=4
| molecular_weight = 291,342 g/mol
| smiles = O=C(c2oc1c(OCC(O)CNC(C)C)cccc1c2)C
| InChI = 1/C16H21NO4/c1-10(2)17-8-13(19)9-20-14-6-4-5-12-7-15(11(3)18)21-16(12)14/h4-7,10,13,17,19H,8-9H2,1-3H3
| InChIKey = ZPQPDBIHYCBNIG-UHFFFAOYAP
| StdInChI_Ref =
| StdInChI = 1S/C16H21NO4/c1-10(2)17-8-13(19)9-20-14-6-4-5-12-7-15(11(3)18)21-16(12)14/h4-7,10,13,17,19H,8-9H2,1-3H3
| StdInChIKey_Ref =
| StdInChIKey = ZPQPDBIHYCBNIG-UHFFFAOYSA-N
}}
Befunolol je beta blokator sa intrinsičnom simpatomimetičkom aktivnošću koji se koristi u tretmanu glaukoma.[1]
- ↑ Stephan Reichl, Christel C Müller-Goymann (2003-02-01). „The use of a porcine organotypic cornea construct for permeation studies from formulations containing befunolol hydrochloride”. International Journal of Pharmaceutics 250 (1): 191–201.
